Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1794872
Max Phase: Preclinical
Molecular Formula: C48H52N4O6S2
Molecular Weight: 845.10
Molecule Type: Small molecule
Associated Items:
ID: ALA1794872
Max Phase: Preclinical
Molecular Formula: C48H52N4O6S2
Molecular Weight: 845.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(-c2nc(SC[C@H]3C[C@@](C)(O)CC(=O)O3)[nH]c2-c2ccc(C)cc2)cc1.Cc1ccc(-c2nc(SC[C@H]3C[C@](C)(O)CC(=O)O3)[nH]c2-c2ccc(C)cc2)cc1
Standard InChI: InChI=1S/2C24H26N2O3S/c2*1-15-4-8-17(9-5-15)21-22(18-10-6-16(2)7-11-18)26-23(25-21)30-14-19-12-24(3,28)13-20(27)29-19/h2*4-11,19,28H,12-14H2,1-3H3,(H,25,26)/t19-,24+;19-,24-/m11/s1
Standard InChI Key: JSSXBAHETYVMBZ-PDTKLIAYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 845.10 | Molecular Weight (Monoisotopic): 844.3328 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Harris NV, Smith C, Ashton MJ, Bridge AW, Bush RC, Coffee EC, Dron DI, Harper MF, Lythgoe DJ, Newton CG.. (1992) Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT., 35 (23): [PMID:1447739] [10.1021/jm00101a016] |
Source(1):